Patient Reported Outcome Data Analysis
Over the past 2 decades, members of COR-LD has pioneered analyzing PRO data for patients with liver disease, including viral hepatitis B and C, non-alcoholic steatohepatitis, cholestatic liver disease, cirrhosis and its complications and liver transplantation.
Learn MoreEconomic Analysis
Assessing the economic burden of a type liver disease or performing cost-effectiveness analysis of different treatment or management strategies are of great importance to fully assess the comprehensive impact of liver disease.
Large Database Analysis
The data team from COR-LD have extensive experience in utilizing a number of publicly available and proprietary databases.
Systematic Review and Meta Analysis
Members of COR-LD have pioneered systematic review and meta-analysis for a number of liver diseases, specifically HCV and NASH.
Learn MoreMeeting Management
COR-LD and its associated councils have significant experience in bringing key opinion leaders from different regions of the world to address specific issues related to liver disease.
Meetings